Microbix Biosystems Stock Today
| MBX Stock | CAD 0.41 0.03 7.89% |
PerformanceWeak
| Odds Of DistressLow
|
Microbix Biosystems is selling at 0.41 as of the 20th of March 2025; that is 7.89% up since the beginning of the trading day. The stock's open price was 0.38. Microbix Biosystems has less than a 9 % chance of experiencing financial distress in the next few years but had a somewhat weak performance during the last 90 days. The performance scores are derived for the period starting the 20th of December 2024 and ending today, the 20th of March 2025. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | Category Healthcare | Classification Health Care |
Microbix Biosystems Inc., a life science company, manufactures viral and bacterial antigens and reagents for the diagnostics industry worldwide. Microbix Biosystems Inc. was founded in 1988 and is based in Mississauga, Canada. MICROBIX J is traded on Toronto Stock Exchange in Canada.. The company has 141.64 M outstanding shares of which 5.25 K shares are now shorted by private and institutional investors with about 0.04 days to cover all short positions. More on Microbix Biosystems
Moving together with Microbix Stock
Moving against Microbix Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Microbix Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Microbix Biosystems' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Microbix Biosystems or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO | Cameron Groome | ||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) | ||||
Microbix Biosystems' financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Microbix Biosystems' success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | |||||
Debt LevelsMicrobix Biosystems can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Microbix Biosystems' financial leverage. It provides some insight into what part of Microbix Biosystems' total assets is financed by creditors.
| |||||
Microbix Biosystems (MBX) is traded on Toronto Exchange in Canada and employs 14 people. Microbix Biosystems is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 57.36 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Microbix Biosystems's market, we take the total number of its shares issued and multiply it by Microbix Biosystems's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Microbix Biosystems operates under Biotechnology sector and is part of Health Care industry. The entity has 141.64 M outstanding shares of which 5.25 K shares are now shorted by private and institutional investors with about 0.04 days to cover all short positions.
Microbix Biosystems has accumulated about 402.12 K in cash with 4.35 M of positive cash flow from operations.
Check Microbix Biosystems Probability Of Bankruptcy
Ownership AllocationMicrobix Biosystems maintains a total of 141.64 Million outstanding shares. Microbix Biosystems secures 14.19 % of its outstanding shares held by insiders and 0.4 % owned by institutional investors. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Microbix Ownership Details
Microbix Biosystems Risk Profiles
Although Microbix Biosystems' alpha and beta are two of the key measurements used to evaluate Microbix Biosystems' performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.81 | |||
| Semi Deviation | 2.88 | |||
| Standard Deviation | 4.31 | |||
| Variance | 18.56 |
Microbix Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Microbix Biosystems without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Earnings Calls Now
Earnings CallsCheck upcoming earnings announcements updated hourly across public exchanges |
| All Next | Launch Module |
Microbix Biosystems Corporate Executives
Elected by the shareholders, the Microbix Biosystems' board of directors comprises two types of representatives: Microbix Biosystems inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Microbix. The board's role is to monitor Microbix Biosystems' management team and ensure that shareholders' interests are well served. Microbix Biosystems' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Microbix Biosystems' outside directors are responsible for providing unbiased perspectives on the board's policies.
| James Currie | Chief Financial Officer | Profile | |
| Kenneth Hughes | Chief Operating Officer | Profile |
Other Information on Investing in Microbix Stock
Microbix Biosystems financial ratios help investors to determine whether Microbix Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Microbix with respect to the benefits of owning Microbix Biosystems security.